I was encouraged by the presentation. It was professional. The licensing deal is coming "shortly". I think the real key is that we will have multiple drugs for multiple indications being developed. The pie is truly getting bigger. Furthermore, this 'parralel' approach should help ensure that we never have a repeat of June 2013 even with a poor BETonMACE result (which I don't expect). Bring on the new monies. Bfw